71 Materials-Science positions at Fred Hutchinson Cancer Center in United-states in United States
-
MINUMUM QUALIFICATIONS: One year of college coursework emphasizing laboratory science or equivalent or one year experience as a Laboratory Tech I or equivalent. PREFERRED QUALIFICATIONS: University/College
-
organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion. The Talbot Lab in the Basic Sciences Division at Fred Hutch seeks a part-time
-
Biology Divisions) works at the intersection of two fields: cell cycle control and the ubiquitin system. While our work focuses on both tumorigenesis and fundamental regulatory mechanisms in normal biology
-
Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion
-
facilities/engineering if cleaning equipment requires repair. Participates in maintaining a safe environment, utilizing the principles of aseptic technique. Assists with the cleaning of the procedural areas
-
Department of Fred Hutch and reports to the Facilities Maintenance Supervisor. The individual will work primarily in the material support section but will also be assigned work orders periodically to balance
-
laboratory. PREFERRED QUALIFICATIONS: Experience culturing bacteria, and especially anaerobic bacteria; with protein expression, especially in vitro protein expression; with molecular biology, particularly
-
Radiation Therapy and Technology by the American Registry of Radiologic Technologists. Washington State License Ability to communicate verbally in person, on the phone and in writing in a clear, concise and
-
workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability
-
and activity. We aim to gain new biological insights into clinically relevant targets and to advance new therapeutic strategies in cancer. We pioneered chemical biology technologies including the dTAG